A phase I trial of afatinib and radiotherapy (Rt) with or without temozolomide (Tmz) in patients with newly diagnosed glioblastoma (Gbm)
Authors
Saran, FJames, A
McBain, Catherine A
Jefferies, S
Harris, F
Cseh, A
Pemberton, K
Schaible, J
Bender, S
Brada, M
Affiliation
The Royal Marsden, SuttonIssue Date
2018
Metadata
Show full item recordCitation
Saran F, James A, McBain C, Jefferies S, Harris F, Cseh A, et al. Actr-38. A phase I trial of afatinib and radiotherapy (Rt) with or without temozolomide (Tmz) in patients with newly diagnosed glioblastoma (Gbm). Neuro-Oncology. 2018;20(suppl_6):vi20-vi.Journal
Neuro-OncologyDOI
10.1093/neuonc/noy148.071Additional Links
https://dx.doi.org/10.1093/neuonc/noy148.071Type
Meetings and ProceedingsLanguage
enae974a485f413a2113503eed53cd6c53
10.1093/neuonc/noy148.071